Uncategorized

F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea – The New York Times

Posted on Author Comments Off on F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea – The New York Times
  1. F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea  The New York Times
  2. FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity  Investors | Eli Lilly and Company
  3. Lilly’s Zepbound Grabs First Drug Approval for Sleep Apnea in US  Bloomberg
  4. FDA approves weight-loss drug Zepbound for obstructive sleep apnea  CNN
  5. FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.  CNBC